Pelthos Therapeutics PTHS
NYSE PTHS
$26.53 +0.69 (+2.67%)
At close: Aug 20, 2026 · 4:00 PM EDT

Pelthos Therapeutics (PTHS) Net Margin (QoQ) (2025 - 2026)

Pelthos Therapeutics (PTHS) Net Margin (QoQ) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn
8 Royalty Pharma 26.98 Bn 26.14 Bn -
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn
10 Pelthos Therapeutics 96.56 Mn 72.00 Mn 21.23 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 5,218.00
Mar 31, 2026 313.00
Dec 31, 2025 539,184.00